Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 154 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1531 7.0 months Recurrent GBM 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 2/2013
Treatment Details: Patients: This phase 2 study involved 37 recurrent glioblastoma patients with a median age of 56 years; 32% were male. Treatment: Patients were treated with the chemotherapy agent temoz
 
1532 7.0 months Advanced hepatocellular carcinoma 4 Biologic therapy
Ain Shams University Egypt 9/2013
Treatment Details: Patients: This involved advanced hepatocellular carcinoma patients who were divided into two separate treatment groups. Group A had 26 patients with a median age of 53.5 years. Group B ha
 
1533 7.0 months Advanced melanoma 4 Immunotherapy
University Hospital of Siena Italy 10/2013
Treatment Details: Patients: This study involved 74 pretreated advanced melanoma patients with a median age of 56 years, 62.2% of whom were male. Treatment: Patients were treated with the immune therapy a
 
1534 7.0 months Metastatic urothelial carcinoma 4 Chemotherapy
Dana-Farber Cancer Institute United States 2/2012
Treatment Details: Patients: This study involved metastatic urothelial cancer patients who had been previously treated with a platinum-based therapy. Patients were divided into two separate treatment groups.
 
1535 7.0 months Metastatic melanoma 5 Biologic therapy
Seattle Cancer Care Alliance United States 2/2012
Treatment Details: Patients: This phase II study involved untreated metastatic melanoma patients who were separated into two separate treatment groups. Group A consisted of 63 patients with a median age of 6
 
1536 7.0 months Metastatic melanoma 4 Biologic therapy
Seattle Cancer Care Alliance United States 2/2012
Treatment Details: Patients: This phase II study involved untreated metastatic melanoma patients who were separated into two separate treatment groups. Group A consisted of 63 patients with a median age of 6
 
1537 7.0 months Advanced or metastatic NSCLC 4 Chemotherapy
UCT-University Cancer Center Germany 2/2013
Treatment Details: Patients: This phase 2 study involved advanced or metastatic non-small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 43 patients with a median
 
1538 7.0 months Metastatic melanoma 4 Mayo Clinic United States 7/2010
Treatment Details: Patients: This phase 2 study involved 17 metastatic melanoma patients. The median patient age was 59 years and 70.6% were male. Treatment: Patients were treated with the biologic thera
 
1539 7.0 months Metastatic urothelial carcinoma 3 Chemotherapy
Stanford University School of Medicine United States 7/2009
Treatment Details: Patients: This phase 2 study involved 11 metastatic urothelial carcinoma patients who had been previously treated with platinum-based chemotherapy. The median patient age was 65 years and
 
1540 7.0 months Advanced urothelial cancer 4 Chemotherapy
Hotel-Dieu de France University Hospital Lebanon 9/2012
Treatment Details: Patients: This phase 2 study involved 27 advanced urothelial cancer patients. The average patient age was 68 years and 81.5% were male. Treatment: Patients were treated with the chemot
 
Page 154 of 187  | Previous Page  | Next Page